What is the market capitalization of Codexis, Inc.?

Codexis, Inc. (CDXS) has a market capitalization of approximately 247,238,662 USD.

How many ETFs hold CDXS?

CDXS is held by 10 ETFs tracked on Investir en Bourse.

Where can I buy CDXS in Canada?

CDXS can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

CDXS

Codexis, Inc.

Codexis, Inc. (CDXS) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 247 million USD (micro-cap).

Details

Price2.72 USD

Market cap247.24 M USD

Payout ratio0.00%

ROE-68.90%

Debt / Equity168.62%

SectorHealthcare

Websitecodexis.com

Updated 3h ago

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.